Development and characterization of anti-spiroperidol antibodies

Kim A. Neve; Daniel E. Casey

doi:10.1016/0006-2952(88)90323-1

Development and characterization of anti-spiroperidol antibodies

Kim A. Neve, Daniel E. Casey

Behavioral Neuroscience

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	3204-3206
Number of pages	3
Journal	Biochemical Pharmacology
Volume	37
Issue number	16
DOIs	https://doi.org/10.1016/0006-2952(88)90323-1
State	Published - Aug 15 1988

ASJC Scopus subject areas

Biochemistry
Pharmacology

Access to Document

10.1016/0006-2952(88)90323-1

Cite this

@article{f995e650b29f44b687a8374a8c459d13,

title = "Development and characterization of anti-spiroperidol antibodies",

author = "Neve, {Kim A.} and Casey, {Daniel E.}",

note = "Funding Information: * Supported by the Veterans Administration Program and the Scottish Rite Schizophrenia Program, U.S.A.",

year = "1988",

month = aug,

day = "15",

doi = "10.1016/0006-2952(88)90323-1",

language = "English (US)",

volume = "37",

pages = "3204--3206",

journal = "Biochemical Pharmacology",

issn = "0006-2952",

publisher = "Elsevier Inc.",

number = "16",

}

TY - JOUR

T1 - Development and characterization of anti-spiroperidol antibodies

AU - Neve, Kim A.

AU - Casey, Daniel E.

N1 - Funding Information: * Supported by the Veterans Administration Program and the Scottish Rite Schizophrenia Program, U.S.A.

PY - 1988/8/15

Y1 - 1988/8/15

UR - http://www.scopus.com/inward/record.url?scp=0024288430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024288430&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(88)90323-1

DO - 10.1016/0006-2952(88)90323-1

M3 - Article

C2 - 3401254

AN - SCOPUS:0024288430

SN - 0006-2952

VL - 37

SP - 3204

EP - 3206

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

IS - 16

ER -

Development and characterization of anti-spiroperidol antibodies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this